By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.
This Startup Just Raised $26 Million To Develop Safer Gene Editing Tools
By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.